Model
Edge
Oyster Point Pharma Inc.
0001783264
Filing type
4
Filing date
Feb 1, 2021
Updated
Feb 2, 2021 ยท 11:35 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership